Charles River Laboratories
Contract research news in brief
December 20, 2010Research and Development Biomodels, CIT, Charles River Laboratories, Dedicated Phase I, INC Research, PPD
Our round-up of recent development in the contract research sector includes updates from Charles River, CIT/Biomodels, INC Research, PPD and …
Charles River calls a halt to WuXi merger plans
August 4, 2010Research and Development Charles River Laboratories, WuXi
Charles River Laboratories has terminated its $1.6 billion agreement to acquire Chinese contract research organisation WuXi PharmaTech after an investor …
Contract research news in brief
July 13, 2010Research and Development Charles River Laboratories, ClinTec, ICON, Quintiles, Synexus, Technical Resources International, WuXi
Charles River places its proposal to merge with China’s WuXi PharmaTech in front of its shareholders, while ClinTec and Synexus …
WuXi posts buoyant increases in revenue and profit
May 13, 2010Research and Development CRO, Charles River, Charles River Laboratories, WuXi
China’s WuXi PharmaTech has given would-be purchaser Charles River Laboratories a lift after posting buoyant increases in both revenues and …
Charles River to buy WuXi for $1.6bn
April 27, 2010Research and Development Charles River, Charles River Laboratories, WuXi, contract research
Contract research and laboratory supplies giant Charles River has said it intends to purchase Chinese counterpart WuXi PharmaTech in a …
Contract research news in brief
January 19, 2010Research and Development Bioanalytical Systems, Charles River Laboratories, Invivodata, Quintiles, ReSearch Pharmaceutical, ReSearch Pharmaceutical Se Invivodata, Synomics Pharma
Our round-up of developments in the world of outsourced R&D includes job losses at Charles River, India’s SIRO Clinpharma buying …
Latest content
FibroFind appoints Lee Borthwick as CEO
